Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Ian Kerridge; Michael Lowe; Michael Seldon; Arno Enno; Sandra Deveridge

doi:10.1001/archinte.1997.00440360189020

Article

August 11, 1997

Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Ian Kerridge, BMed, MPhil; Michael Lowe, BMed; Michael Seldon, MBBS, BSc Med, FRACP, FRCPA; et al Arno Enno, MBBS, FRACP, FRCPA; Sandra Deveridge, MBBS, BSc Med

Author Affiliations

From the Health Law and Ethics Program, University of Newcastle (Drs Kerridge and Lowe), and the Hematology Unit, Mater Hospital (Drs Kerridge, Seldon, Enno, and Deveridge), Newcastle, Australia.

Arch Intern Med. 1997;157(15):1753-1757. doi:10.1001/archinte.1997.00440360189020

Full Text

Abstract

We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.

Arch Intern Med. 1997;157:1753-1757

Full Text

Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Others Also Liked

Featured Articles

USPSTF Recommendation Statements

Blogs

Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Citation

Manage citations:

Others Also Liked

Select Your Interests